Importantly, as opposed to the down-regulation of BEX2 expression observed in gliobalstoma there is a relative overexpression of this gene in breast tumors, which suggests a difference in the transcriptional regulation of BEX2 between these cancers [1,6]. The gene discussed is BEX2; the disease is cancer.